Efficacy, Safety of the Ad5-nCoV Vaccine for Protection Against COVID-19
Researchers conducted a study to determine the safety and efficacy of the Ad5-nCoV vaccine for protection against SARS-CoV-2 infection in adult patients.
All articles by Bradley van Paridon
Efficacy of the NVX-CoV2373 COVID-19 Vaccine Co-Administered With Seasonal Influenza Vaccines
Researchers conducted a study to assess the efficacy of the NVX-CoV2373 COVID-19 vaccine when co-administered with a seasonal influenza vaccine.
Healthy Diet Associated With Lower Risk for and Severity of COVID-19
Investigators assessed the association between diet quality and risk for and severity of COVID-19, as well as its relationship with socioeconomic deprivation.
Hospitalization Risk in High-Risk Patients With COVID-19 Treated With Fluvoxamine
Researchers conducted a study that assessed the effect of fluvoxamine treatment on the risk for hospitalization among patients with SARS-CoV-2 infection at increased risk for progression to severe disease.
Biomarker Combination Shows High Diagnostic Accuracy in Primary Sjögren Syndrome
Researchers determined the diagnostic potential of serum anti-SSA/Ro and upregulated salivary protein biomarkers in patients with primary Sjögren syndrome.
Outcomes and Prognostic Factors of Older Adults Hospitalized With COVID-19
Despite being the most vulnerable population, a significant portion of older adult patients hospitalized with severe COVID-19 survived the infection, including those treated in an intensive care unit.
Macular Structure and Microvasculature Degeneration in Patients With AIDS-Related Cytomegalovirus Retinitis
Researchers sought to assess the occurrence of macular and microvasculature structure degeneration among patients with active and inactive AIDS-related cytomegalovirus retinitis.
Increased Odds of Venous Thromboembolism For Patients With IBD and SARS-CoV-2
Investigators assessed the risk of developing a venous thromboembolism in patients with IBD who have also contracted SARS-CoV-2.
NVX-CoV2373 Nanoparticle Vaccine Effective Against COVID-19 B.1.351 Variant
A phase 2a-b study was conducted in South Africa to assess the safety and efficacy of the NVX-CoV2373 vaccine.
Antibody Response to 1 Dose SARS-CoV-2 mRNA Vaccine in Previously Infected HCWs
Investigators assessed if healthcare workers with previous SARS-CoV-2 infections mount better responses to a single dose of an mRNA vaccine than those without previous infection.
- Loading...
Loading...
Next post in Systemic Ophthalmology
Loading... 
Loading...